Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-351148      Publish Date : Saturday, April 9, 2016 Visit : 1316

Intl. Congress form | International Congress Report | International Congress Report For Faculty | Congenital and Structural Interventions

Congenital and Structural Interventions
The report of Congenital and Structural Interventions by Dr. Keyhan Sayadpour Zanjani
Application Code :
306-0215-0134
 
Created Date : Wednesday, November 11, 2015 22:44:39Update Date : Tuesday, February 2, 2016 19:11:15
IP Address : 194.225.212.150Submit Date : Tuesday, February 2, 2016 19:11:31Email : sayadpour@tums.ac.ir
Personal Information
Name : Keyhan
Surname : Sayadpour Zanjani
School/Research center : School of Medicine
If you choose other, please name your Research center :  
Position : Assistant professor
Tel : +98-21-22132219
Information of Congress
Title of the Congress : Congenital and Structural Interventions
Title of your Abstract : Ductal stenting beyond neonatal period: Is it acceptable as a substitute to a surgical shunt?
Destination Country : Germany
From : Thursday, June 25, 2015
To : Saturday, June 27, 2015
Abstract(Please copy/paste the abstract send to the congress) : CSI 2015
Category: Coarctation and Ductus
Title: Ductal stenting beyond neonatal period: Is it acceptable as a substitute to a surgical shunt
Authors: Keyhan Sayadpour Zanjani, AliakbarZeinaloo, Reza Shabanian, Zahra Mousavi
Affiliation: Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Objectives: Ductal stenting is increasingly used as a substitute to surgical shunt in neonates due to lesser traumatic burden and complication rate. Reported uses of this method in older patients are rare. If effective, it may be reasonable to use it in older patients as well.
Materials: Since February 2014, we have used ductal stenting to increase pulmonary blood flow in seven patients older than 2 months with pulmonary atresia and ventricular septal defects (3-96 months old, median 14). Cobalt-chromium stents were used in all patients due to their excellent trackability (either peripheral Palmaz Blue or coronary Kaname stents). Five stents were implanted via femoral artery and two from axillary artery.
Results: Oxygen saturation increased between 7 to 35% (median 20) after stenting. The older patients had the worst results. In the oldest patient, we could only stent the distal ductus arteriosus due to the narrow aortic side. A major aortopulmonarry collateral artery stenting made the procedure favorable. The next oldest (59 months) had a tight obstruction at the middle of the duct which could not be dilated with a high pressure balloon (14 atm). The third patient (22 months) developed a waist at the middle of the stent which was relieved by a high pressure balloon at a second catheterization.
Conclusion: Ductal stenting can be a good substitute for surgical shunts in patients younger than 2 years.
Corresponding author: Keyhan Sayadpour Zanjani, MD; Children’s Medical Center, 62 Dr Gharib St, 14194 Tehran, Iran; Fax: +98-21-66930024; Email: ksayadpour@gmail.com
Keywords of your Abstract : Patent ductus arteriosus, stent, children
Acceptance Letter : http://gsia.tums.ac.ir/images/UserFiles/11588/Forms/306/Gmail_-_ici_CSI_2015_Frankfurt_-_your_abstract_case_has_been_accepted_for_e-poster_presentation.pdf
The presentation : Poster
The Cover of Abstract book : http://gsia.tums.ac.ir/images/UserFiles/11588/Forms/306/Cover.pdf
Published abstract in the abstract book with the related code : http://gsia.tums.ac.ir/images/UserFiles/11588/Forms/306/Abstract.pdf
Where has your abstract been indexed? : none
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : around 1000
Delegates from which countries presented in the congress? : all continents of the world including Iran, Germany, Italy, Egypt, Brasil, Saudi Arabia, Polland, ...
Were the delegates of any other organizations present in the congress? : No
If yes, please write the names of the organizations in the box :  
What were the responses to your talking points? Were specific questions or concerns raised? : Yes. We discussed about the results of my study. There were colleagues who agreed with my suggestions and ones who opposed. I participated in the best poster competition which I lost to a polish colleague.
If you met staff members, please list their full names & positions. : Professor Ahmet Celebi from Turkey, Prof Shakeel Qureshi from UK
Please inform us if there are any follow up actions we need to talk with the members of the congress : The actions were good and friendly. The pediatric interventionists worldwide knows each other very well and everything was well.The congress is relatively old and well prepared. As it is a long time that it is held in a constant congress center each year, it is easy to reach it and as I participated for the 5th time, I know the location and nearby hotels very well.
Your experiences about the travel processes(Providing ticket, accommodation,...) : I have not any problem as I travel every year or other day to tha same congress.
Please give a briefing of your own observations and outcomes of the congress: : In this congress, new interventions and therapeutic procedured and new devices and method was presented. This congress is the largest one in Europe and after PICS in USA, the second largest in the world.Long program (sometimes 12 hours a day) rich of live cases, oral lectures by top professors in this field, many discussions, and new experiences make it very useful. Every other year I participate in this meeting and I learn many new things which I use them in my practice and teaching to my fellows. I will participate in the next meetings as well. I recommend it to every pediatric or adult interventionist who like to learn more in this field.